Actinium Pharmaceuticals News - ATNM

Company Name	Stock Ticker Symbol	Market	Type
Actinium Pharmaceuticals Inc	ATNM	AMEX	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.00	0.0%	5.26	04:00:00

Open Price	Low Price	High Price	Close Price	Prev Close
				5.26

more quote information »

Recent News

Date	Time	Source	Heading
12/01/2023	17:00	EDGAR2	Form 8-K - Current report
11/09/2023	17:09	EDGAR2	Form ARS - Annual Report to Security Holders
11/09/2023	17:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
11/06/2023	07:30	PRNUS	Actinium Presents Preclinical Data at SITC Demonstrating..
11/02/2023	16:15	PRNUS	Actinium Pharmaceuticals to Attend Bio-Europe Munich 2023
11/02/2023	09:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/2023	09:05	PRNUS	Actinium Announces Oral Presentation at ASH Annual Meeting..
10/04/2023	07:30	PRNUS	Actinium Announces NIH Grant Extension to Advance Clinical..
9/27/2023	09:05	PRNUS	Actinium Pharma Highlights Abstract Accepted for Poster..
9/07/2023	08:40	PRNUS	Actinium Pharma Presents Survival Data from Extended..
8/31/2023	07:00	PRNUS	Actinium Pharma Highlights Three Abstracts Accepted for..
8/21/2023	07:00	PRNUS	Actinium Pharma Highlights Abstracts Accepted for Oral and..
8/14/2023	17:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/2023	09:00	EDGAR2	Form S-3 - Registration statement under Securities Act of..
7/24/2023	07:00	PRNUS	Actinium Pharma to Present at the 2nd Annual Targeted..
6/26/2023	07:00	PRNUS	SNMMI 2023 Annual Meeting Abstract of the Year Awarded to..
6/23/2023	08:00	PRNUS	Actinium Pharma Highlights Six Abstracts Accepted for Oral..
6/16/2023	07:00	PRNUS	Actinium Pharma to Present at the Maxim Healthcare Virtual..
6/14/2023	07:00	PRNUS	Actinium Pharma to Present at the TD Cowen..
6/12/2023	07:00	PRNUS	Actinium Announces Positive Pivotal Phase 3 SIERRA Trial..
6/07/2023	07:00	PRNUS	Actinium Pharma Set to Join Russell 2000® and Russell 3000®..
5/22/2023	07:00	PRNUS	Actinium Pharma Announces Six Abstracts Accepted for Oral..
5/11/2023	11:18	PRNUS	Actinium Pharma Announces Iomab-B SIERRA Trial Results..
5/10/2023	07:00	PRNUS	Actinium Pharma to Present at Guggenheim Healthcare Talks..
4/28/2023	08:00	PRNUS	Actinium Highlights Successful Administration of Targeted..
4/27/2023	10:36	PRNUS	Actinium Announces Positive Pivotal Phase 3 SIERRA Trial..
12/12/2022	11:05	TRMN	JonesTrading Keeps Their Buy Rating on Actinium..
12/09/2022	09:25	TRMN	Actinium Pharmaceuticals (ATNM) Receives a Buy from B.Riley..